Medicine & Pharmaceuticals
CanVeer Receives IPON Approval for Initial Funding to Advance Intellectual Property Strategy
Mississauga, CanadaCanVeer Biopharma Inc. (the “Company” or “CanVeer”), a biopharma company advancing innovative therapeutics for severe neonatal conditions, is pleased to announce that it…
